BP000265-CHM-256: Recombinant Human Eotaxin (CCL11)
Source: E. coli-derived.
The activity is determined by the chemoattract of human PBE (peripheral blood eosinophils) at a concentration between 0.1-10 ug/ml corresponding to a Specific Activity of 10,000-10,000,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000265-CHM-260: Recombinant Rat Eotaxin (CCL11)
Source: E. coli-derived.
Fully biologically active. Determined by its ability to chemoattract purified blood eosinophils using a concentration range of 0.1-1.0 ug/ml, corresponding to a Specific Activity of 10-100 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000265-CHM-308: Recombinant Mouse Eotaxin (CCL11)
Source: E. coli-derived.
The Biological activity was determined by measuring the dose dependent phosphorylation of ERK1 and ERK2 in CCR3 transfected 293 cells. Significant ERK phosphorylation is observed with >100 ug/ml (corresponding to a Specific Activity of 10000 IU/mg) of recombinant mouse eotaxin.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000265-CHM-344: Recombinant Human Eotaxin (CCL11), His Tag
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.